Therapy News and Research

RSS

Mississippi’s cervical cancer deaths indicate broader health care problems

Shementé Jones knew something wasn't right. Her back hurt. She felt pain during sex.

5 Sep 2023

Can ChatGPT be a diabetes consultant? Study probes the potential and pitfalls

This comprehensive study explores ChatGPT's ability to answer questions about diabetes, comparing it to human experts in a Danish diabetes center. While familiar users could more often spot the AI-generated answers, the research underscores the need for rigorous evaluation and safe integration of AI in healthcare.

5 Sep 2023

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

4 Sep 2023

Silencing two genes can make cancer cells receptive to chemotherapy

Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to it.

4 Sep 2023

Big Tuna and automated buffer exchange: An interview with Unchained Labs

In this interview, AZoNetwork speaks with Joe Barco, the Senior Director of Workflow Marketing at Unchained Labs, about the benefits of automated buffer exchange with Big Tuna.

From Unchained Labs 4 Sep 2023

New breakthroughs by NPL scientists could transform cancer treatment

New breakthroughs by scientists at the National Physical Laboratory (NPL) are set to transform cancer treatment in the UK and worldwide.

4 Sep 2023

Faster mental health treatment could reduce financial burden on the NHS, improve outcomes

The study, which is one of the largest of its kind to date, analysed anonymised data, and was conducted by ieso Digital Health Ltd in partnership with Dorset HealthCare University NHS Trust and York Health Economics Consortium (part of the University of York).

4 Sep 2023

Survey highlights the lack of awareness about deadly chronic acid reflux

A new survey has revealed the overwhelming lack of knowledge about the causes and symptoms of hiatus hernia and chronic acid reflux in the UK. These results come despite the fact that 1 in 3 people aged over 50 have hiatus hernia and 13 million people suffer from chronic acid reflux.

4 Sep 2023

Research reveals 71% of men in the UK are struggling to sleep through the night

New research, from men’s healthcare company Numan, suggests there is a sleep crisis among UK men with 71% of men surveyed struggling to sleep through the night.

4 Sep 2023

Innovate UK funding to support the development of powdered gene therapy for bone graft augmentation

TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency.

4 Sep 2023

Study finds ways to improve medication adherence in breast cancer survivors

For roughly 80% of breast cancer survivors, treatment doesn't end with surgery, radiation and chemotherapy. Instead, for the next five to 10 years, doctors recommend that they take medication to block sex hormones, which can fuel tumor growth and spark recurrence.

1 Sep 2023

Integrating HIV and addiction treatment improves outcomes for people who inject drugs in Russia

New research from Boston Medical Center found that providing pragmatic support, specifically rapid access to antiretroviral therapy, pharmacotherapy for opioid use disorder, and strengths-based case management, improved treatment outcomes for people with HIV who inject drugs in St. Petersburg, Russia.

1 Sep 2023

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not make a difference in outcomes for treating patients with an advanced form of thyroid cancer that develops from thyroid follicular cells called differentiated thyroid cancer (DTC).

1 Sep 2023

International consortium to study link between RSV infection and chronic respiratory tract diseases

UMC Utrecht will lead an international consortium that will try to answer a key question that's in the mind of many pediatricians, infectiologists, pulmonologists and other health professionals: "Why are children that had an RSV infection in early childhood at increased risk of developing asthma later in life?"

1 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

The safety and efficacy of anti-androgens in managing polycystic ovary syndrome (PCOS).

1 Sep 2023

TherageniX and University of Nottingham awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

Funding from Innovate UK’s Transforming Medicines Manufacturing program supporting innovative technologies for intracellular drug delivery.

1 Sep 2023

Therapy News and Research

Mississippi’s cervical cancer deaths indicate broader health care problems

Can ChatGPT be a diabetes consultant? Study probes the potential and pitfalls

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

Silencing two genes can make cancer cells receptive to chemotherapy

Big Tuna and automated buffer exchange: An interview with Unchained Labs

New breakthroughs by NPL scientists could transform cancer treatment

Faster mental health treatment could reduce financial burden on the NHS, improve outcomes

Survey highlights the lack of awareness about deadly chronic acid reflux

Research reveals 71% of men in the UK are struggling to sleep through the night

Innovate UK funding to support the development of powdered gene therapy for bone graft augmentation

Study finds ways to improve medication adherence in breast cancer survivors

Integrating HIV and addiction treatment improves outcomes for people who inject drugs in Russia

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

International consortium to study link between RSV infection and chronic respiratory tract diseases

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

TherageniX and University of Nottingham awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

Redo TAVR procedures are safe and effective, study shows

New gene therapy offers hope for beta thalassemia patients

Discovery could lead to more effective treatments for cancers

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News